| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Pharmacyclics Looks to Continue to Trade Above its Annual-High Share Price Today | | - | SmarTrend |
| 23.05.
| How High Can Pharmacyclics Fly? | | 3 | Motley Fool |
| 22.05.
| Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association | | 11 | PR Newswire |
| SUNNYVALE, Calif., May 22, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that clinical abstracts on Bruton's Tyrosine Kinase inhibitor, ibrutinib (formerly, PCI-32765)...
Mehr lesen zu:
Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association | |
| 17.05.
| Needham erhöht das Kursziel für Pharmacyclics von$23 auf $32 | | 87 | BörseGo |
| Needham erhöht das Kursziel für Pharmacyclics von$23 auf $32
(© BörseGo AG 2012 - Autor: Simon Hauser, Redakteur)
Mehr lesen zu:
Needham erhöht das Kursziel für Pharmacyclics von$23 auf $32 | |
| 17.05.
| Best Relative Performance in the Healthcare Sector Detected in Shares of Pharmacyclics | | - | SmarTrend |
| 17.05.
| Pharmacyclics Rising Today on Above-Average Volume | | - | SmarTrend |
| 17.05.
| 2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc. | | 17 | MarketWire |
| HONG KONG -- (Marketwire) -- 05/17/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Acorda Therapeutics Inc (NASDAQ: ACOR) and Pharmacyclics, Inc. (NASDAQ: PCYC). Gain market...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc. | |
| 17.05.
| Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology | | 14 | PR Newswire |
| SUNNYVALE, Calif., May 17, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that clinical abstracts on Bruton's Tyrosine Kinase inhibitor, ibrutinib (formerly, PCI-32765) have...
Mehr lesen zu:
Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology | |
| 10.05.
| PHARMACYCLICS INC - 10-Q, Quarterly Report | | - | SEC Filings |
| 10.05.
| Pharmacyclics Bullish Moving Average Crossover Alert | | - | SmarTrend |
| 10.05.
| Pharmacyclics Reports Fiscal 2012 Third Quarter Financial Results and Recent Developments | | 16 | PR Newswire |
| SUNNYVALE, Calif., May 10, 2012 /PRNewswire/ --
Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results and recent developments for its fiscal third quarter ended March 31...
Mehr lesen zu:
Pharmacyclics Reports Fiscal 2012 Third Quarter Financial Results and Recent Developments | |
| 04.05.
| Pharmacyclics has the Highest Operating Margin in the Biotechnology Industry | | 1 | SmarTrend |
| 19.04.
| Pharmacyclics Bullish Moving Average Crossover Alert | | 5 | SmarTrend |
| 12.04.
| Possible Bullish Inside Day Candle Pattern Detected for Pharmacyclics | | - | SmarTrend |
| 11.04.
| FDA Designates Orphan Status for Pharmacyclics (PCYC) CLL Treatment | | 2 | StreetInsider.com |
| 09.04.
| Pharmacyclics Crosses Below its 10-day MA | | 1 | SmarTrend |
| 05.04.
| Shares of Pharmacyclics Rank the Highest in Terms of Operating Margin in the Biotechnology Industry | | 1 | SmarTrend |
| 04.04.
| Innovations Leading to Gains in the Biotech Industry / Five Star Equities Provides Stock Research on Pharmacyclics, Inc. and Onyx Pharmaceuticals, Inc. | | 29 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 04/04/12 -- They say you never want to catch a falling knife, but what to do with a rising star such as the Biotech Industry? Biotech stocks have continued to impress...
Mehr lesen zu:
Innovations Leading to Gains in the Biotech Industry / Five Star Equities Provides Stock Research on Pharmacyclics, Inc. and Onyx Pharmaceuticals, Inc. | |
| 02.04.
| Uptrend Call Working As Pharmacyclics Stock Rises 81.5% | | 2 | SmarTrend |
| 02.03.
| Pharmacyclics to Host a Conference Call on March 15, 2012 to Discuss Second Quarter Fiscal 2012 Financial and Operational Results | | 69 | PR Newswire |
| SUNNYVALE, Calif., March 1, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment...
Mehr lesen zu:
Pharmacyclics to Host a Conference Call on March 15, 2012 to Discuss Second Quarter Fiscal 2012 Financial and Operational Results | |
